Evidence map›Paper›PMID 35015586›Full record

ArticleJCO oncology practice2022

Impact of COVID-19 on Hematology-Oncology Fellowship Programs: A Quantitative and Qualitative Survey Assessment of Fellowship Program Directors.

Ana I Velazquez, Urshila Durani, Lachelle D Weeks, Ajay Major, Robby Reynolds, Ashok Kumbamu, Devika G Das, Martina C Murphy, Elizabeth Henry, Alfred I Lee and 1 more

Open access · greenAbstract read
In one paragraph

Article in JCO oncology practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Interactive Pathology Tutorial in Neoplastic Hematology Disorders for Medical Hematology-Oncology Fellows.Journal of cancer education : the official journal of the American Association for Cancer Education · 2024
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 9 institutions in 1 country.

Ana I VelazquezDivision of Hematology and Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA.ORCID 0000-0002-6153-5557
Urshila DuraniDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN.ORCID 0000-0003-1860-2424
Lachelle D WeeksDana Farber Cancer Institute, Boston, MA.ORCID 0000-0001-8726-6212
Ajay MajorSection of Hematology and Oncology, Department of Medicine, University of Chicago, Chicago, IL.ORCID 0000-0001-7261-1335
Robby ReynoldsAmerican Society of Hematology, Washington, DC.
Ashok KumbamuCenter for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN.
Devika G DasDivision of Hematology and Oncology, University of Alabama Medical Center, Birmingham, AL.
Martina C MurphyDivision of Hematology and Oncology, University of Florida, Gainesville, FL.
Elizabeth HenryDepartment of Medical Education, Loyola University Medical Center, Maywood, IL.ORCID 0000-0003-2948-3985
Alfred I LeeSection of Hematology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT.ORCID 0000-0002-5968-3948
Ariela L MarshallDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN.ORCID 0000-0001-7388-0422
Mayo Clinic in Arizona · USAmerican Society of Hematology · USDana-Farber Cancer Institute · USLoyola University Medical Center · USUniversity of Alabama · USUniversity of California, San Francisco · USUniversity of Chicago · USUniversity of Florida · USYale University · US

Funding

RESOURCE CENTER FOR AGING RESEARCH IN DIVERSE POPULATIONP30AG015272 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Nynikka Palmer · 1997 to 2026
$19.5M
NIA NIH HHS P30 AG015272
6 · The paper itself

Abstract

purposeThe COVID-19 pandemic led to unprecedented challenges in medical training, and we sought to assess the specific impact of COVID-19 on hematology-oncology (HO) fellowship programs.

methodsWe conducted a cross-sectional anonymous online survey of 103 HO program directors (PDs) in conjunction with the American Society of Hematology (ASH) and ASCO. We sought to assess the specific impact of COVID-19 on HO fellowship programs' clinical, educational, and research activities, evaluate perceptions regarding PD and trainee emotional and mental health, and identify ways to support programs. Data were analyzed using descriptive statistics, parametric and nonparametric tests, and multivariable logistic regression models. Responses to open-ended questions were analyzed with thematic analysis.

resultsSignificant changes to fellowship activities included transitioning fellow training from outpatient clinics to telehealth (77.7%), shifting to virtual education (94.2%), and moving to remote research work (63.1%). A minority (21.4%) of PDs reported that their fellows were redeployed to cover non-HO services. Most PDs (54.4%) believed COVID-19 had a slight negative impact on fellowship training. PD self-reported burnout increased significantly from 15.5% prepandemic to 44.7% during the pandemic, and most PDs witnessed minor signs of fellow burnout (52.4%). Common PD concerns included inadequate supervision for telehealth activities, reduced opportunities for fellow advancement and promotion, lack of professional development activities, limited research operations and funding, program financial constraints, and virtual recruitment.

conclusionWe encourage institutions and national societies to allocate resources and develop programs that can support fellowships and mitigate the potential negative effects of COVID-19 on trainee and PD career development.

Indexed as

COVID-19HematologyCross-Sectional StudiesEducation, Medical, GraduateFellowships and ScholarshipsHumansPandemics

Identifiers

PMID35015586
PMCPMC9014421
OpenAlexW4205795433

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.